Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families

Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-pho...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary research (Paris) Vol. 43; no. 1; pp. 60 - 197
Main Authors: Robert-Tissot, Céline, Rüegger, Vera L, Cattori, Valentino, Meli, Marina L, Riond, Barbara, Moore, Peter F, Engels, Monika, Franchini, Marco, Hofmann-Lehmann, Regina, Lutz, Hans
Format: Journal Article
Language:English
Published: London BioMed Central 20.08.2012
BioMed Central Ltd
BMC
Subjects:
ISSN:1297-9716, 0928-4249, 1297-9716
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae , Herpesviridae , Caliciviridae , Parvoviridae , and Retroviridae . Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro . Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.
AbstractList Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.
Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.
Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae , Herpesviridae , Caliciviridae , Parvoviridae , and Retroviridae . Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro . Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.
Abstract Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial importance in shelters and catteries, where cats from different backgrounds have narrow contacts. Oligonucleotides (ODN) containing cytosine-phosphate-guanosine motifs of class A (CpG-A) are highly potent synthetic inducers of innate antiviral mechanisms. The aim of this study was to test their ability to modulate innate immune responses and prevent viral replication as stand-alone agents in the domestic cat. CpG-A stimulation of feline peripheral blood mononuclear cells (PBMCs) enhanced their proliferation, increased the presence of co-stimulatory molecules on their surface and influenced their gene expression profiles in an antiviral orientation. Incubation of the supernatants of CpG-A stimulated PBMCs with feline cell lines of epithelial and fibroblastic origin induced expression of the antiviral myxovirus resistance (Mx) gene in these target cells, which also showed enhanced resistance to feline viruses from five distinct families, namely Coronaviridae, Herpesviridae, Caliciviridae, Parvoviridae, and Retroviridae. Most importantly, subcutaneous administration of CpG-A in domestic cats systemically increased the expression of Mx, reaching maximal levels within 24 h. Plasma from treated cats could furthermore inhibit viral replication in vitro. Altogether, our data highlight the promising potential of CpG-A to induce a preventive antiviral state in the cat and to protect feline populations against a broad range of virus infections.
Audience Academic
Author Engels, Monika
Franchini, Marco
Hofmann-Lehmann, Regina
Moore, Peter F
Rüegger, Vera L
Robert-Tissot, Céline
Meli, Marina L
Riond, Barbara
Lutz, Hans
Cattori, Valentino
AuthorAffiliation 1 Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland
2 Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA
3 Institute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland
AuthorAffiliation_xml – name: 3 Institute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstrasse 266a, 8057, Zürich, Switzerland
– name: 1 Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland
– name: 2 Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA
Author_xml – sequence: 1
  givenname: Céline
  surname: Robert-Tissot
  fullname: Robert-Tissot, Céline
  email: crobert@vetclinics.uzh.ch
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 2
  givenname: Vera L
  surname: Rüegger
  fullname: Rüegger, Vera L
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 3
  givenname: Valentino
  surname: Cattori
  fullname: Cattori, Valentino
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 4
  givenname: Marina L
  surname: Meli
  fullname: Meli, Marina L
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 5
  givenname: Barbara
  surname: Riond
  fullname: Riond, Barbara
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 6
  givenname: Peter F
  surname: Moore
  fullname: Moore, Peter F
  organization: Department of Pathology, Microbiology and Immunology, 3315 Vet Med 3A, School of Veterinary Medicine, University of California
– sequence: 7
  givenname: Monika
  surname: Engels
  fullname: Engels, Monika
  organization: Institute of Virology, Vetsuisse Faculty, University of Zürich
– sequence: 8
  givenname: Marco
  surname: Franchini
  fullname: Franchini, Marco
  organization: Institute of Virology, Vetsuisse Faculty, University of Zürich
– sequence: 9
  givenname: Regina
  surname: Hofmann-Lehmann
  fullname: Hofmann-Lehmann, Regina
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
– sequence: 10
  givenname: Hans
  surname: Lutz
  fullname: Lutz, Hans
  organization: Clinical Laboratory, Vetsuisse Faculty, University of Zurich
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22906110$$D View this record in MEDLINE/PubMed
BookMark eNqFkktv1DAUhSNURB-wZocssWEzrR07drJBqkZQKlViAawtP65nPErswU4GseOn43Ta0kFUKItc3Zzz2Uc5p9VRiAGq6jXB54S0_ILUnVh0gvAFowuOn1UnD5ujR_NxdZrzBmPCacNeVMd13WFOCD6pfn0Z_TD1avQxoB9-XCOFTK9yRpdoub1CsferGCbTQxy9BQRhrYKBjBJkn8d5RmNEPjgwfxgOeh8A7XyactG6FAfk_A6Q9c5BgjAipwbfe8gvq-dO9Rle3b3Pqm8fP3xdflrcfL66Xl7eLAzHeFxorlWjOgeN0FjxhilhXdPYVmuLVccZNhaMbgihBjQQy6iiurMOsGXcCXpWXe-5NqqN3CY_qPRTRuXl7SKmlVRp9CWoVJobTJionXCMCaOFqLnpOm6Z5i2zhfV-z9pOegBrSp6k-gPo4Zfg13IVd5I2VDSsK4B3d4AUv0-QRzn4bKDvVYA4ZUkY43XLa8r-L60Frcut2pn6di9dqZKi_JJYDjezXF42lLG25mwGnv9DVR4LgzelXs6X_YHhzeO0DzHvS1QEzV5gUsw5gZPGj7eNKmTfS4LlXFY511HOdZSMSj77Lv7y3aOfduC9IxdlWEGSmzilUHrzpOU3rw779Q
CitedBy_id crossref_primary_10_3390_v12060640
crossref_primary_10_3390_v13091736
crossref_primary_10_1016_j_vetmic_2014_10_031
crossref_primary_10_1016_j_jcpa_2018_11_001
crossref_primary_10_1016_j_vetimm_2012_07_015
crossref_primary_10_1016_j_ijbiomac_2025_144105
crossref_primary_10_3390_ani11123548
crossref_primary_10_1186_1297_9716_43_82
ContentType Journal Article
Copyright Robert-Tissot et al.; licensee BioMed Central Ltd. 2012
COPYRIGHT 2012 BioMed Central Ltd.
Copyright ©2012 Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 Robert-Tissot et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: Robert-Tissot et al.; licensee BioMed Central Ltd. 2012
– notice: COPYRIGHT 2012 BioMed Central Ltd.
– notice: Copyright ©2012 Robert-Tissot et al.; licensee BioMed Central Ltd. 2012 Robert-Tissot et al.; licensee BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOA
DOI 10.1186/1297-9716-43-60
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic

AGRICOLA
MEDLINE



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
EISSN 1297-9716
EndPage 197
ExternalDocumentID oai_doaj_org_article_ab6c01472f7f447cb7726c996d4b684d
PMC3537549
A534482644
22906110
10_1186_1297_9716_43_60
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Switzerland
GeographicLocations_xml – name: Switzerland
GroupedDBID ---
0R~
123
2VQ
2WC
4.4
53G
5VS
AAFWJ
AAHBH
AAJSJ
AASML
ACGFS
ACGOD
ADBBV
ADRAZ
ADUKV
AENEX
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BFQNJ
BMC
C6C
CS3
DIK
DU5
E3Z
EBLON
EBS
EJD
F5P
FRP
FYUFA
GROUPED_DOAJ
H13
HYE
IAG
IAO
INH
INR
IPNFZ
ITC
KQ8
M41
M48
O5R
O5S
OK1
PGMZT
RBZ
RED
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
--K
1B1
7X7
88E
88I
8FI
8FJ
AAOTM
AAYXX
ABUBZ
ABUWG
AFFHD
AFKRA
AZQEC
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
DWQXO
EBD
ECGQY
EMOBN
EYRJQ
GI~
GNUQQ
HCIFZ
HMCUK
IHE
M1P
M2P
NQ-
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RPZ
SV3
TR2
UKHRP
-A0
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c600t-b6ba5a9fe57b0a654a7df55d8bbd0a9640cdecb5113cebe1d43a3b9dfe0d46f73
IEDL.DBID RSV
ISICitedReferencesCount 8
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000313159900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1297-9716
0928-4249
IngestDate Fri Oct 03 12:51:48 EDT 2025
Tue Sep 30 16:44:22 EDT 2025
Wed Oct 01 13:49:38 EDT 2025
Thu Sep 04 15:54:29 EDT 2025
Mon Oct 20 22:50:26 EDT 2025
Mon Oct 20 16:57:58 EDT 2025
Thu Jan 02 22:44:12 EST 2025
Sat Nov 29 06:05:03 EST 2025
Tue Nov 18 21:07:17 EST 2025
Sat Sep 06 07:20:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Feline Cell
Viral Inhibition Assay
Vesicular Stomatitis Virus
Proviral Load
CrFK Cell
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-b6ba5a9fe57b0a654a7df55d8bbd0a9640cdecb5113cebe1d43a3b9dfe0d46f73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://link.springer.com/10.1186/1297-9716-43-60
PMID 22906110
PQID 1273268489
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_ab6c01472f7f447cb7726c996d4b684d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3537549
proquest_miscellaneous_1446286234
proquest_miscellaneous_1273268489
gale_infotracmisc_A534482644
gale_infotracacademiconefile_A534482644
pubmed_primary_22906110
crossref_citationtrail_10_1186_1297_9716_43_60
crossref_primary_10_1186_1297_9716_43_60
springer_journals_10_1186_1297_9716_43_60
PublicationCentury 2000
PublicationDate 2012-08-20
PublicationDateYYYYMMDD 2012-08-20
PublicationDate_xml – month: 08
  year: 2012
  text: 2012-08-20
  day: 20
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Veterinary research (Paris)
PublicationTitleAbbrev Vet Res
PublicationTitleAlternate Vet Res
PublicationYear 2012
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References 19651532 - Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95
17507184 - Vet Microbiol. 2007 Jul 20;123(1-3):180-6
20384481 - Oligonucleotides. 2010 Apr;20(2):93-101
17548588 - J Immunol. 2007 Jun 15;178(12):7540-9
20003366 - BMC Mol Biol. 2009;10:106
17521745 - Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):68-74
21204950 - Microbiol Immunol. 2011 Mar;55(3):184-90
15879022 - Clin Diagn Lab Immunol. 2005 May;12(5):606-21
15454922 - Nat Immunol. 2004 Oct;5(10):987-95
12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
15541797 - Vet Immunol Immunopathol. 2004 Dec 28;102(4):441-50
15070685 - Blood. 2004 Apr 15;103(8):3058-64
10515269 - Vet Microbiol. 1999 Sep 1;69(1-2):51-3
15174975 - Expert Opin Biol Ther. 2004 Jun;4(6):937-46
9764403 - J Vet Med Sci. 1998 Aug;60(8):911-7
8757300 - J Immunol. 1996 Sep 1;157(5):1840-5
16678920 - Antiviral Res. 2006 Oct;72(1):42-8
17067685 - Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):24-34
10623843 - J Immunol. 2000 Jan 15;164(2):944-53
9558060 - J Immunol. 1998 Apr 15;160(8):3627-30
12414749 - Clin Diagn Lab Immunol. 2002 Nov;9(6):1192-9
18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68
15051512 - Cell Immunol. 2004 Jan;227(1):24-37
7515537 - Vet Microbiol. 1994 Mar;39(1-2):145-52
9725240 - J Immunol. 1998 Sep 1;161(5):2428-34
15123152 - J Feline Med Surg. 2004 Apr;6(2):83-8
1808993 - Adv Exp Med Biol. 1991;310:17-27
21452145 - Schweiz Arch Tierheilkd. 2011 Apr;153(4):157-64
20577268 - Nat Rev Immunol. 2010 Jul;10(7):514-26
16585590 - J Immunol. 2006 Apr 15;176(8):4940-9
15708635 - Antiviral Res. 2005 Feb;65(2):87-95
14977922 - Infect Immun. 2004 Mar;72(3):1223-9
21719112 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):269-81
6166723 - J Exp Med. 1981 Jul 1;154(1):199-203
20619456 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e111-7
11179339 - Infect Immun. 2001 Mar;69(3):1643-9
15771947 - J Feline Med Surg. 2005 Apr;7(2):109-19
17943118 - Nature. 2007 Oct 18;449(7164):819-26
15127838 - Vet Immunol Immunopathol. 2004 Mar;98(1-2):17-29
9862683 - J Immunol. 1998 Dec 15;161(12):6567-74
4308914 - J Virol. 1969 Aug;4(2):147-53
11777536 - Vet Immunol Immunopathol. 2002 Jan 15;84(3-4):223-36
17760705 - Vet Ophthalmol. 2007 Sep-Oct;10(5):278-84
11449369 - Eur J Immunol. 2001 Jul;31(7):2154-63
16740097 - Am J Vet Res. 2006 Jun;67(6):1025-32
12502811 - J Virol. 2003 Jan;77(2):953-62
10430938 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10
7700380 - Nature. 1995 Apr 6;374(6522):546-9
12242445 - Science. 2002 Sep 20;297(5589):2063-6
15096181 - Immunology. 2004 May;112(1):28-37
12243889 - Vet Microbiol. 2002 Oct 22;89(2-3):115-27
12572939 - Vet Rec. 2003 Jan 25;152(4):105-8
9645386 - Eur J Immunol. 1998 Jun;28(6):2045-54
17981343 - Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):241-50
17339052 - Mol Immunol. 2007 May;44(12):3234-42
10623847 - J Immunol. 2000 Jan 15;164(2):973-85
17909979 - Vet Res Commun. 2008 Feb;32(2):167-74
11035094 - J Immunol. 2000 Oct 15;165(8):4537-43
14745443 - Nat Med. 2004 Feb;10(2):187-92
15470059 - J Immunol. 2004 Oct 15;173(8):5148-55
9973506 - J Immunol. 1999 Feb 15;162(4):2291-8
8610135 - Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83
12469940 - Int Immunopharmacol. 2002 Nov;2(12):1657-66
15383597 - J Immunol. 2004 Oct 1;173(7):4627-34
11182501 - Vet Microbiol. 2001 Feb 26;78(4):353-62
17683972 - Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):425-33
12778481 - Eur J Immunol. 2003 Jun;33(6):1633-41
11745345 - Eur J Immunol. 2001 Nov;31(11):3281-90
18432822 - Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.9
15000839 - Oligonucleotides. 2003;13(4):245-59
11763350 - Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40
10640783 - J Immunol. 2000 Feb 1;164(3):1617-24
11825597 - Vet Immunol Immunopathol. 2002 Jan 1;84(1-2):43-59
19505421 - Vet Res. 2009 Sep-Oct;40(5):45
11970999 - J Immunol. 2002 May 1;168(9):4531-7
10811870 - J Exp Med. 2000 May 15;191(10):1777-88
14971051 - Eur J Immunol. 2004 Jan;34(1):251-62
16698199 - Vet Microbiol. 2006 Oct 5;117(1):14-8
11130078 - Nature. 2000 Dec 7;408(6813):740-5
14511239 - Immunology. 2003 Oct;110(2):250-7
14504106 - Blood. 2004 Feb 1;103(3):1030-2
16054243 - J Virol Methods. 2005 Dec;130(1-2):124-32
9593061 - Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4
9765447 - J Virol. 1998 Nov;72(11):9025-33
17457344 - Nat Rev Immunol. 2007 May;7(5):379-90
16584295 - Oligonucleotides. 2006 Spring;16(1):58-67
20964643 - Clin Exp Immunol. 2010 Dec;162(3):494-9
20133174 - Vet J. 2011 Mar;187(3):381-7
12773511 - J Leukoc Biol. 2003 Jun;73(6):781-92
References_xml – reference: 9764403 - J Vet Med Sci. 1998 Aug;60(8):911-7
– reference: 10811870 - J Exp Med. 2000 May 15;191(10):1777-88
– reference: 15879022 - Clin Diagn Lab Immunol. 2005 May;12(5):606-21
– reference: 12502811 - J Virol. 2003 Jan;77(2):953-62
– reference: 17339052 - Mol Immunol. 2007 May;44(12):3234-42
– reference: 21719112 - Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):269-81
– reference: 11130078 - Nature. 2000 Dec 7;408(6813):740-5
– reference: 15123152 - J Feline Med Surg. 2004 Apr;6(2):83-8
– reference: 8757300 - J Immunol. 1996 Sep 1;157(5):1840-5
– reference: 20133174 - Vet J. 2011 Mar;187(3):381-7
– reference: 17909979 - Vet Res Commun. 2008 Feb;32(2):167-74
– reference: 20003366 - BMC Mol Biol. 2009;10:106
– reference: 12242445 - Science. 2002 Sep 20;297(5589):2063-6
– reference: 7700380 - Nature. 1995 Apr 6;374(6522):546-9
– reference: 14511239 - Immunology. 2003 Oct;110(2):250-7
– reference: 17683972 - Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):425-33
– reference: 15708635 - Antiviral Res. 2005 Feb;65(2):87-95
– reference: 6166723 - J Exp Med. 1981 Jul 1;154(1):199-203
– reference: 12469940 - Int Immunopharmacol. 2002 Nov;2(12):1657-66
– reference: 11825597 - Vet Immunol Immunopathol. 2002 Jan 1;84(1-2):43-59
– reference: 15127838 - Vet Immunol Immunopathol. 2004 Mar;98(1-2):17-29
– reference: 16698199 - Vet Microbiol. 2006 Oct 5;117(1):14-8
– reference: 20619456 - Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e111-7
– reference: 19505421 - Vet Res. 2009 Sep-Oct;40(5):45
– reference: 20384481 - Oligonucleotides. 2010 Apr;20(2):93-101
– reference: 11970999 - J Immunol. 2002 May 1;168(9):4531-7
– reference: 11777536 - Vet Immunol Immunopathol. 2002 Jan 15;84(3-4):223-36
– reference: 16054243 - J Virol Methods. 2005 Dec;130(1-2):124-32
– reference: 18432822 - Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.9
– reference: 12773511 - J Leukoc Biol. 2003 Jun;73(6):781-92
– reference: 9593061 - Antisense Nucleic Acid Drug Dev. 1998 Apr;8(2):181-4
– reference: 15454922 - Nat Immunol. 2004 Oct;5(10):987-95
– reference: 9725240 - J Immunol. 1998 Sep 1;161(5):2428-34
– reference: 17067685 - Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):24-34
– reference: 17521745 - Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):68-74
– reference: 12184808 - Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
– reference: 9973506 - J Immunol. 1999 Feb 15;162(4):2291-8
– reference: 17943118 - Nature. 2007 Oct 18;449(7164):819-26
– reference: 12243889 - Vet Microbiol. 2002 Oct 22;89(2-3):115-27
– reference: 9765447 - J Virol. 1998 Nov;72(11):9025-33
– reference: 15000839 - Oligonucleotides. 2003;13(4):245-59
– reference: 10623843 - J Immunol. 2000 Jan 15;164(2):944-53
– reference: 19651532 - Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95
– reference: 15383597 - J Immunol. 2004 Oct 1;173(7):4627-34
– reference: 11763350 - Antisense Nucleic Acid Drug Dev. 2001 Oct;11(5):333-40
– reference: 10515269 - Vet Microbiol. 1999 Sep 1;69(1-2):51-3
– reference: 16584295 - Oligonucleotides. 2006 Spring;16(1):58-67
– reference: 18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68
– reference: 11035094 - J Immunol. 2000 Oct 15;165(8):4537-43
– reference: 17548588 - J Immunol. 2007 Jun 15;178(12):7540-9
– reference: 11182501 - Vet Microbiol. 2001 Feb 26;78(4):353-62
– reference: 12778481 - Eur J Immunol. 2003 Jun;33(6):1633-41
– reference: 9862683 - J Immunol. 1998 Dec 15;161(12):6567-74
– reference: 21452145 - Schweiz Arch Tierheilkd. 2011 Apr;153(4):157-64
– reference: 12572939 - Vet Rec. 2003 Jan 25;152(4):105-8
– reference: 7515537 - Vet Microbiol. 1994 Mar;39(1-2):145-52
– reference: 14745443 - Nat Med. 2004 Feb;10(2):187-92
– reference: 17760705 - Vet Ophthalmol. 2007 Sep-Oct;10(5):278-84
– reference: 11179339 - Infect Immun. 2001 Mar;69(3):1643-9
– reference: 11745345 - Eur J Immunol. 2001 Nov;31(11):3281-90
– reference: 9558060 - J Immunol. 1998 Apr 15;160(8):3627-30
– reference: 15771947 - J Feline Med Surg. 2005 Apr;7(2):109-19
– reference: 20964643 - Clin Exp Immunol. 2010 Dec;162(3):494-9
– reference: 14977922 - Infect Immun. 2004 Mar;72(3):1223-9
– reference: 17457344 - Nat Rev Immunol. 2007 May;7(5):379-90
– reference: 15051512 - Cell Immunol. 2004 Jan;227(1):24-37
– reference: 15096181 - Immunology. 2004 May;112(1):28-37
– reference: 14971051 - Eur J Immunol. 2004 Jan;34(1):251-62
– reference: 10640783 - J Immunol. 2000 Feb 1;164(3):1617-24
– reference: 16585590 - J Immunol. 2006 Apr 15;176(8):4940-9
– reference: 10430938 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9305-10
– reference: 17981343 - Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):241-50
– reference: 21204950 - Microbiol Immunol. 2011 Mar;55(3):184-90
– reference: 12414749 - Clin Diagn Lab Immunol. 2002 Nov;9(6):1192-9
– reference: 15541797 - Vet Immunol Immunopathol. 2004 Dec 28;102(4):441-50
– reference: 14504106 - Blood. 2004 Feb 1;103(3):1030-2
– reference: 20577268 - Nat Rev Immunol. 2010 Jul;10(7):514-26
– reference: 10623847 - J Immunol. 2000 Jan 15;164(2):973-85
– reference: 15070685 - Blood. 2004 Apr 15;103(8):3058-64
– reference: 4308914 - J Virol. 1969 Aug;4(2):147-53
– reference: 17507184 - Vet Microbiol. 2007 Jul 20;123(1-3):180-6
– reference: 15470059 - J Immunol. 2004 Oct 15;173(8):5148-55
– reference: 8610135 - Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2879-83
– reference: 16740097 - Am J Vet Res. 2006 Jun;67(6):1025-32
– reference: 16678920 - Antiviral Res. 2006 Oct;72(1):42-8
– reference: 11449369 - Eur J Immunol. 2001 Jul;31(7):2154-63
– reference: 15174975 - Expert Opin Biol Ther. 2004 Jun;4(6):937-46
– reference: 9645386 - Eur J Immunol. 1998 Jun;28(6):2045-54
– reference: 1808993 - Adv Exp Med Biol. 1991;310:17-27
SSID ssj0016354
Score 2.0388618
Snippet Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of primordial...
Abstract Domestic cats are commonly affected by viral pathogens that induce lengthy infections with fatal outcomes. Prevention of viral propagation is of...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 60
SubjectTerms Animals
B cells
Caliciviridae
Cat Diseases - immunology
Cat Diseases - prevention & control
Cat Diseases - virology
Cats
Cell Line
Cell Proliferation
Coronaviridae
epithelial cells
Feline leukemia virus
Flow Cytometry - veterinary
Gene expression
Gene Expression Regulation
gene targeting
Genetic aspects
Health aspects
Herpesviridae
Immune response
immunity
Immunity, Innate
Immunology
Infection
Leukocytes, Mononuclear - immunology
Male
Medicine
Medicine & Public Health
Microbiology
mononuclear leukocytes
Myxovirus Resistance Proteins - genetics
Myxovirus Resistance Proteins - metabolism
Oligodeoxyribonucleotides - administration & dosage
Oligodeoxyribonucleotides - pharmacology
Oligonucleotides
Parvoviridae
pathogens
Phosphates
Physiological aspects
Random Allocation
Real-Time Polymerase Chain Reaction - veterinary
Retroviridae
Species Specificity
subcutaneous injection
Veterinary Medicine/Veterinary Science
Virology
Virus Diseases - immunology
Virus Diseases - prevention & control
Virus Diseases - veterinary
Virus Diseases - virology
Virus Replication
viruses
Viruses - classification
Viruses - immunology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQxYELgvIVKMhISMAhNLt27OS4VBQOUCEBVW-WP2mkklSbbM_8dGYcZ2mKChduq7U3G3ue7Tf2-A0hLwAWtmBS59oBgrn3NtdBg7MSai65Zy5EAdPjj_LoqDo5qT9fSvWFMWGjPPDYcfvaCAs0Xi6DDJxLa4AOCgss3XEjKu5w9gXWMzlT6fwAltEoHFXj3hF4GEnUZ1GJfVjgZI7CSTlneVSm_L0eRdn-PyfnS6vT1cjJK8encVU6vENuJzpJV2Mz7pIbvt0lu8cY4xIv2tJP6ez8Hvn5ZWh-pGRdFLdfqaYWuTNd0YPz97Q7a753Lcobd0PjPPXtKSKip-CQI8mEz3To6BS9lZ4R8D67pxfNetNDXbytQgPMoHTKvDLQuIcCDvl98u3w3deDD3nKv5BboEFDboTRpa6DL6UptCi5lmC60lXGuELXghfWeWuAsjELWFg4zjQztQu-cFwEyR6QnbZr_SNCy4XmpRPBoPvHAtKKUNUauFowzhU2I28mKyibxMkxR8aZik5KJRSaTaHZFGdKFBl5tf3B-ajLcX3Vt2jWbTUU1I5fAMxUgpn6F8wy8hJBoXDYw4tZnW4vQPNQQEutSgaOLrLLjOzNasJwtbPi5xOsFBZhjFvru00Pry0Zau9U9V_q8HiXeMngOQ9HKG7bFZX7gc1lRM5AOmv4vKRtTqOiOCsxEzL87-sJzipNZf11vfr4f_TqE3ILCOgS9-iXxR7ZGdYb_5TctBdD06-fxSH9C47ET9s
  priority: 102
  providerName: Directory of Open Access Journals
Title Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families
URI https://link.springer.com/article/10.1186/1297-9716-43-60
https://www.ncbi.nlm.nih.gov/pubmed/22906110
https://www.proquest.com/docview/1273268489
https://www.proquest.com/docview/1446286234
https://pubmed.ncbi.nlm.nih.gov/PMC3537549
https://doaj.org/article/ab6c01472f7f447cb7726c996d4b684d
Volume 43
WOSCitedRecordID wos000313159900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: Open Access: BioMedCentral Open Access Titles
  customDbUrl:
  eissn: 1297-9716
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016354
  issn: 1297-9716
  databaseCode: RBZ
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1297-9716
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016354
  issn: 1297-9716
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1297-9716
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016354
  issn: 1297-9716
  databaseCode: RSV
  dateStart: 20111201
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGQIiXAeVjhVEZCQl4CKS1YyeP3cTgASa0QVXxYvlzizSSqU33zJ_OnZtUZDAkeKmq-JLYzs--O_vuZ0JeACxsyqROtAMEc-9tooMGZyUUXHLPXIgEprOP8ugon8-Lz1tk3OXCxGj3bksyztRxWOfiLSgmmSDhUcJZIsBLvwm6LsexeHwy22wcgP7kLYPPH27qKZ_I0f_7TPyLKroaJnllrzSqoMO7_1H5e2SntTfpdA2Q-2TLVwNy-1O7oz4ggxnGw8SkXNpdfUB-nDTl9_ZgL4pLtVRTi3Y2ndKDi_e0Pi9P6wqpkOumdJ766gzRs6TgvKNBCv9pU9Mu0qt9RsDcd08vy8VqCbKY2UIDzLa0O6WloXG9BZz3h-Tr4bsvBx-S9qyGxILJ1CRGGJ3pIvhMmlSLjGsJnzlzuTEu1YXgqXXeGjDvmAXcjB1nmpnCBZ86LoJkj8h2VVd-l9BsrHnmRDDoKrKAJkjICw12XTDOpXZI3nQfUdmWyBzP0zhX0aHJhcLeVtjbijMl0iF5tbnhYs3hcb3oPqJiI4bk2_FCvThV7VhW2ggLnqWcBBk4l9aAhyIsOI6OG5FzNyQvEVMKpwiomNVtpgM0D8m21DRj4BSjJTokez1JGNq2V_y8Q6XCIoyHq3y9WkK1JUOenrz4iwyPeccTBs95vEbypl2R5R8svyGRPYz3Gt4vqcqzyD7OMjw1Gd77ukO6aqe95XW9-uQfZJ-SO2CTTnDZfpLuke1msfLPyC172ZTLxYjckPN8FBdO4Pd4_9soDv-fp5tWEQ
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqgoALj-W1UMBISMAhJbt27OS4VJQititES9Wb5WcbqSTVbrZnfjoz3mRFCkWCWxRPEtv57JmxZz4T8gpgYVMmdaIdIJh7bxMdNDgroeCSe-ZCJDA9msrZLD8-Lr5skFGXCxOj3bstyThTx2Gdi3egmGSChEcJZ4kAL_0aB3WFUXxfD47WGwegP3nL4POHh3rKJ3L0_z4T_6KKLodJXtorjSpo985_VP4uud3am3SyAsg9suGrAbmx3-6oD8jgCONhYlIu7e7eJz8OmvJ7e7AXxaVaqqlFO5tO6M75R1qflSd1hVTIdVM6T311iuhZUHDe0SCFa9rUtIv0at8RMPfd04tyvlyALGa20ACzLe1OaWloXG8B5_0B-bb74XBnL2nPakgsmExNYoTRmS6Cz6RJtci4lvCbM5cb41JdCJ5a560B845ZwM3IcaaZKVzwqeMiSPaQbFZ15R8Tmo00z5wIBl1FFtAECXmhwa4LxrnUDsl29xOVbYnM8TyNMxUdmlwo7G2Fva04UyIdkjfrB85XHB5Xi75HVKzFkHw73qjnJ6ody0obYcGzlOMgA-fSGvBQhAXH0XEjcu6G5DViSuEUARWzus10gOYh2ZaaZAycYrREh2SrJwlD2_aKX3aoVFiE8XCVr5cLqLZkyNOTF3-R4THveMzgPY9WSF63K7L8g-U3JLKH8V7D-yVVeRrZx1mGpybDd992SFfttLe4qlef_IPsC3Jz73B_qqafZp-fkltgn45xCX-cbpHNZr70z8h1e9GUi_nzOPB_Ap9YVgk
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQQBMvfJSvwAAjIQEP2bLasZPHMiggRjVpUO3N8ucWaSRVk-6ZP527NKnIYEiItyq-pLHz8_nOvvsdIS8BFjZhUsfaAYK59zbWQYOzEnIuuWcutASm80M5m2UnJ_lRF5tT99Hu_ZHkOqcBWZrKZm_hwnqKZ2IPFikZI_lRzFkswGO_zrFiEDrrx_PNIQKspbxj8_nDTYOFqOXr_10r_7IsXQ6ZvHRu2i5H09v_2ZE75FZnh9LJGjh3yTVfjsj2l-6kfURGc4yTaZN1aX_1Hvlx3BTfu4JfFLdwqaYW7W86oQeLD7Q6L06rEimSq6ZwnvryDFFVU3Dq0VCF37SpaB8B1j0jYE68pxfFclWDLGa80ABamPbVWxra7sOAU3-ffJu-_3rwMe5qOMQWTKkmNsLoVOfBp9IkWqRcS_j8qcuMcYnOBU-s89aA2ccs4GnfcaaZyV3wieMiSPaAbJVV6R8Rmu5rnjoRDLqQLKBpErJcg70XjHOJjchu_0GV7QjOsc7GuWodnUwoHG2Fo604UyKJyOvNDYs1t8fVom8RIRsxJOVuL1TLU9XNcaWNsOBxynGQgXNpDXguwoJD6bgRGXcReYX4Uqg64MWs7jIgoHtIwqUmKQNnGS3UiOwMJGHK20Hzix6hCpswTq701aqG15YM-Xuy_C8yvM1HHjN4zsM1qjf9atn_wSKMiBzgfdDxYUtZnLWs5CzFasrwv2961KtOHdZXjerjf5B9TraP3k3V4afZ5yfkJpitY9zZHyc7ZKtZrvxTcsNeNEW9fNbqgJ-2m17t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stimulation+with+a+class+A+CpG+oligonucleotide+enhances+resistance+to+infection+with+feline+viruses+from+five+different+families&rft.jtitle=Veterinary+research+%28Paris%29&rft.au=Robert-Tissot%2C+C%C3%A9line&rft.au=R%C3%BCegger%2C+Vera+L&rft.au=Cattori%2C+Valentino&rft.au=Meli%2C+Marina+L&rft.date=2012-08-20&rft.pub=BioMed+Central&rft.issn=0928-4249&rft.eissn=1297-9716&rft.volume=43&rft.issue=1&rft.spage=60&rft.epage=60&rft_id=info:doi/10.1186%2F1297-9716-43-60&rft_id=info%3Apmid%2F22906110&rft.externalDocID=PMC3537549
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1297-9716&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1297-9716&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1297-9716&client=summon